General Surgery Department, Zhongshan Hospital, Fudan University, Shanghai, China.
Shanghai Engineering Research Center of Colorectal Cancer Minimally Invasive, Shanghai, China.
J Surg Oncol. 2021 Sep;124(4):607-618. doi: 10.1002/jso.26552. Epub 2021 Jun 2.
This study aimed to find the advantages of robotic natural orifice specimen extraction surgery (NOSES) for middle and low rectal cancer, compared with traditional laparoscopic low anterior resection (LAR).
Patients receiving robotic NOSES or traditional laparoscopic LAR were retrospectively enrolled from 2013-10 to 2019-06, with middle and low rectal cancer, maximum diameter ≤ 5 cm, pT1-3 or ypT1-3 stage, no distant metastases. The baseline of the two groups was balanced using the propensity score matching method. Surgical quality, postoperative recovery, and long-term oncological outcomes were compared.
Totally 137 eligible patients with robotic NOSES and 137 matched patients with traditional laparoscopic LAR were enrolled. Robotic NOSES had a significantly lower open conversion rate (0 vs. 4.4%, p = .030), less intraoperative hemorrhage (50 ml vs. 80 ml, p < .001) and longer distance from distal resection margin of low rectal cancer (1.5 cm vs. 1.0 cm, p = .030). Robotic NOSES significantly reduced the 30-day postoperative complication rate of Clavien-Dindo grade II or higher (17.5% vs. 31.4%, p = .008), promoted gastrointestinal and urinary function recovery, reduced postoperative pain and hospital stay (6.0 vs. 7.0 d, p = .022). The two groups were similar in long-term survival.
Compared with traditional laparoscopic LAR, robotic NOSES had significant advantages in improving surgical quality and promoting postoperative recovery.
本研究旨在比较机器人经自然腔道标本取出手术(NOSES)与传统腹腔镜低位前切除术(LAR)治疗中低位直肠癌的优势。
回顾性纳入 2013 年 10 月至 2019 年 6 月接受机器人 NOSES 或传统腹腔镜 LAR 的中低位直肠癌患者,肿瘤最大直径≤5cm,pT1-3 或 ypT1-3 期,无远处转移。采用倾向评分匹配法平衡两组患者的基线。比较两组患者的手术质量、术后恢复情况和长期肿瘤学结果。
共纳入 137 例符合条件的机器人 NOSES 患者和 137 例匹配的传统腹腔镜 LAR 患者。机器人 NOSES 的中转开腹率显著更低(0% vs. 4.4%,p=0.030),术中出血量更少(50ml vs. 80ml,p<0.001),低位直肠癌远端切缘距离更长(1.5cm vs. 1.0cm,p=0.030)。机器人 NOSES 显著降低了 30 天术后 Clavien-Dindo 分级Ⅱ级或以上的并发症发生率(17.5% vs. 31.4%,p=0.008),促进了胃肠道和泌尿功能的恢复,减轻了术后疼痛和住院时间(6.0d vs. 7.0d,p=0.022)。两组患者的长期生存情况相似。
与传统腹腔镜 LAR 相比,机器人 NOSES 在提高手术质量和促进术后恢复方面具有显著优势。